Registration statement for securities of certain foreign private issuers

Segment Information - Summary of Segments and Reconciliation Operations as per Segment Information (Detail)

v3.21.2
Segment Information - Summary of Segments and Reconciliation Operations as per Segment Information (Detail) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Disclosure of operating segments [line items]        
Revenue $ 128,771 $ 22,503 $ 79,272 $ 16,034
Inter-segment revenue 0 0 0 0
Segment revenue 128,771 22,503 79,272 16,034
Cost of care delivery (92,137) (18,820) (67,254) (19,810)
Other operating expenses, excluding amortization and depreciation (101,862) (80,082) (173,042) (156,548)
Exchange (loss)/gain (91) (2,146) (2,836) (17,075)
Share of loss of equity-accounted investees (1,276) (309) (1,124)  
Gain / (loss) on sale 3,917 0    
EBITDA (62,678) (78,854) (164,984) (143,249)
Depreciation and amortization (13,322) (6,459) (14,487) (2,496)
Operating loss (78,550) (82,858) (175,511) (162,820)
Operating segments [member]        
Disclosure of operating segments [line items]        
Revenue 129,591 22,503 79,194 16,043
Inter-segment revenue (50) 0 (134) 30
Segment revenue 129,541 22,503 79,060 16,073
Cost of care delivery (97,434) (24,444) (76,186) (26,240)
Other operating expenses, excluding amortization and depreciation (98,816) (74,540) (158,942) (148,508)
Exchange (loss)/gain 2,095 (19,908) 17,217 16,815
Share of loss of equity-accounted investees (1,276) (309) (1,124)  
Gain / (loss) on sale 1,490      
EBITDA (64,399) (96,698) (139,975) (141,860)
Material reconciling items [member]        
Disclosure of operating segments [line items]        
Revenue (820) 0 78 (9)
Inter-segment revenue 50 0 134 (30)
Segment revenue (770) 0 212 (39)
Cost of care delivery (5,297) (5,624) 8,932 6,430
Other operating expenses, excluding amortization and depreciation (3,046) (5,542) (14,100) (8,040)
Exchange (loss)/gain (2,187) 17,762 (20,053) 260
Share of loss of equity-accounted investees 0 0 0  
Gain / (loss) on sale 2,427      
EBITDA 1,721 17,844 (25,009) (1,389)
UK        
Disclosure of operating segments [line items]        
Revenue 56,616 19,302 44,000 14,633
Inter-segment revenue 0 0 1,194 4,081
Segment revenue 56,616 19,302 45,194 18,714
Cost of care delivery (20,545) (18,581) (34,600) (25,707)
Other operating expenses, excluding amortization and depreciation (59,667) (57,704) (127,762) (119,895)
Exchange (loss)/gain (182) (813) 403 314
Share of loss of equity-accounted investees 0 0 0  
Gain / (loss) on sale (2,390)      
EBITDA (26,168) (57,796) (116,765) (126,574)
US        
Disclosure of operating segments [line items]        
Revenue 72,071 2,097 32,226 0
Inter-segment revenue 0 0 (3,094) (2,669)
Segment revenue 72,071 2,097 29,132 (2,669)
Cost of care delivery (75,951) (3,040) (34,381) (160)
Other operating expenses, excluding amortization and depreciation (32,976) (10,618) (27,190) (23,273)
Exchange (loss)/gain (70) 197 (246) (83)
Share of loss of equity-accounted investees (1,276) (309) 0  
Gain / (loss) on sale 0      
EBITDA (38,202) (11,673) (32,685) (26,185)
All other segments [member]        
Disclosure of operating segments [line items]        
Revenue 904 1,104 2,968 1,410
Inter-segment revenue (50) 0 1,766 (1,382)
Segment revenue 854 1,104 4,734 28
Cost of care delivery (938) (2,823) (7,205) (373)
Other operating expenses, excluding amortization and depreciation (6,173) (6,218) (3,990) (5,340)
Exchange (loss)/gain 2,348 (19,292) 17,060 16,584
Share of loss of equity-accounted investees 0 0 (1,124)  
Gain / (loss) on sale 3,880      
EBITDA $ (29) $ (27,229) $ 9,475 $ 10,899